Light therapy and fluvoxamine in the treatment of bipolar psychotic depression: A pilot study

Linda Franchini, Simone Ballan, Cristina Colombo, Enrico Smeraldi

Research output: Contribution to journalArticle

Abstract

Objective: The aim of the study is to evaluate the tolerability and efficacy of adjunctive light therapy in a sample of psychotically depressed bipolar inpatients treated with fluvoxamine pharmacotherapy. Method: 27 subjects affected by bipolar disorder and hospitalized for a major depressive episode with psychotic features were treated with fluvoxamine 300 mg either alone or in combination with light therapy. Light was administered daily in 30 minutes sessions and timed according to individual chronotypes. HDRS and DDERS were used to assess clinical changes over time. Results: After six weeks of treatment overall remission rate was 80.8% (HDRS

Original languageEnglish
Pages (from-to)166-173
Number of pages8
JournalClinical Neuropsychiatry
Volume6
Issue number4
Publication statusPublished - 2009

Keywords

  • Bipolar disorder
  • Fluvoxamine
  • Light therapy
  • Psychotic depression

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Light therapy and fluvoxamine in the treatment of bipolar psychotic depression: A pilot study'. Together they form a unique fingerprint.

  • Cite this